
Alx Oncology Holdings (ALXO)
US$ 1.3125.96%
Price Chart
Key Statistics
Market Cap
$ 28.45M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
13.13M
52W High
$ 17.82
52W Low
$ 0.46
Dividend Yield
0.00%
Beta
1.20
Technicals
50-Day MA
0.7337
200-Day MA
1.7418
52 Week High
17.825
52 Week Low
0.46
About ALXO
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.
Employees
80
Headquarters
South San Francisco, CA
CEO
Mr. Jason W. Lettmann
Latest News
Will ALXO Make A Comeback In July? - RTTNews
Yesterday • Google News
Why ALX Oncology Holdings Inc. (ALXO) Soared on Thursday - Yahoo Finance
2025-03-07 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg